VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 129 filers reported holding VBI VACCINES INC in Q3 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,932 | -45.2% | 12,610 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -18.2% | 12,610 | -7.1% | 0.00% | – |
| Q2 2022 | $11,000 | -35.3% | 13,573 | +35.2% | 0.00% | – |
| Q1 2022 | $17,000 | -26.1% | 10,037 | 0.0% | 0.00% | – |
| Q4 2021 | $23,000 | -32.4% | 10,037 | -8.2% | 0.00% | – |
| Q3 2021 | $34,000 | – | 10,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |